Skip to main content
Premium Trial:

Request an Annual Quote

ProGenTech, Innovative Biosensors Partner on Dx System

NEW YORK (GenomeWeb News) – ProGenTech and Innovative Biosensors jointly announced today that they will develop a rapid, integrated diagnostic system incorporating their respective technologies.

The collaboration will combine Innovative Biosensors' Cellular Analysis and Notification of Antigen Risks and Yields technology with ProGenTech's Enture Lite platform, which is a cassette-based system that contains reagents for RNA, DNA, protein, and cell-based testing applications. According to Emeryville, Calif.-based ProGenTech, the system enables the user to add samples to the cassettes, load the cassette into the Entura system, then press a button to start the analysis and walk away.

Innovative Biosensors' CANARY technology was developed at the Massachusetts Institute of Technology. It consists of engineered biosensors that express membrane-bound, pathogen-specific antibodies and a calcium-sensitive bioluminescent molecule. The cross-linking of antibodies of specific pathogens leads to elevated intracellular calcium and light emission, the Rockville, Md.-based firm said.

Financial and other terms of the partnership were not disclosed.

Privately held ProGenTech also is developing a series of molecular diagnostic assays and a fully integrated system for detecting hospital-acquired infections. The firm's Chairman and CEO, Trevor Hawkins, is a former director of the department of Energy's Joint Genome Institute, a former CEO of Philips Molecular Healthcare and MDS, and a former executive at Amersham and GE.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.